Article
Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein.
Virology journal - 25 May 2011
Ali Ijaz, Khan Sanaullah, Attaullah Sobia, Khan Shahid Niaz, Khan Jabbar, Siraj Sami, Iqbal Aqib, Swati Zahoor A, Idrees Muhammad
Abstract excerpt
BACKGROUND: Hepatitis C virus (HCV) genotype 3a is known to show comparatively better response to combination therapy than genotype 1 and 4. Mutations within NS5A gene of HCV have earlier been implicated with response to interferon (IFN) therapies in chronic HCV patients among various populations. As response to therapy are available in different populations because of the ethnic and viral factors and there was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
